Acute and late GI toxicity (grade 2+) · People with urological (prostate) and gynaecological (endometrial) cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (grade 2+) · People with urological (prostate) and gynaecological (endometrial) cancer
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
QoL · People with urological (prostate) and gynaecological (endometrial) cancer
1 finding from 1 review
Mean GI symptom scores · People with urological (prostate) and gynaecological (endometrial) cancer
1 finding from 1 review
Reduction in pain intensity · chronic pain (excluding headache) in adults
1 finding from 1 review
Functional disability at 3 months ‐ not measured · chronic pain (excluding headache) in adults
1 finding from 1 review
Disability at · chronic pain (excluding headache) in adults
1 finding from 1 review
Distress at · chronic pain (excluding headache) in adults
2 findings from 1 review
AEs · chronic pain (excluding headache) in adults
Pain intensity (measure on a 0‐3 four‐point scale) · chronic pain (excluding headache) in adults
1 finding from 1 review
Disability at the end of treatment as measured by multiple scales including RMDQ, AIMS Higher scores indicate higher levels of disability · chronic pain (excluding headache) in adults
1 finding from 1 review
Disability at · chronic pain (excluding headache) in adults
1 finding from 1 review
Distress at · chronic pain (excluding headache) in adults
2 findings from 1 review
AEs · chronic pain (excluding headache) in adults
1 finding from 1 review
Reduction in pain intensity · chronic pain (excluding headache) in adults
Pain intensity (measure on a 0‐3 four‐point scale) · chronic pain (excluding headache) in adults
1 finding from 1 review
Change in weight (kg) · adults with cystic fibrosis
It is very uncertain whether summary of findings: ECM changes change in weight (kg) compared with NECT plus cimetidine (very low certainty).
1 finding from 1 review
Change in BMI · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abdominal pain frequency or change in frequency · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: ECM changes frequency of bowel symptoms: abdominal pain (% of days affected) compared with ECT (very low certainty).
1 finding from 1 review
CFA: change in FFE (g/day) · adults and children with cystic fibrosis
Summary of findings: ECM showed no clear difference in CFA: change in FFE (g/day) compared with ECT (low certainty).
1 finding from 1 review